J. Montseny, G. Trawale, and F. Moret, Beaufils for their 585 kind contributions to this study, p.11

C. Röcken and K. Sletten, Amyloid in surgical pathology, Virchows Arch, vol.588443, pp.3-16, 2003.

P. Westermark, K. Sletten, and M. Eriksson, Morphologic and chemical 590 variation of the kidney lesions in amyloidosis secondary to rheumatoid 591 arthritis, Lab Invest, vol.41, pp.427-458, 1979.

H. Falck, T. Törnroth, and O. Wegelius, Predominantly vascular amyloid 593 deposition in the kidney in patients with minimal or no proteinuria

L. Looi, Histomorphological variations in systemic AA amyloidosis: clues of AA protein polymorphism, Histopathology, vol.701, issue.2, pp.111-131, 1989.
DOI : 10.1002/path.1700940210

H. Uda, A. Yokota, and K. Kobayashi, Two distinct clinical courses of 598 renal involvement in rheumatoid patients with AA amyloidosis, J 599 Rheumatol, vol.33, pp.1482-1489, 2006.

N. Scolding, F. Joseph, and P. Kirby, A??-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy, Brain, vol.128, issue.3, pp.500-515, 2005.
DOI : 10.1093/brain/awh379

A. Argiles, G. Garcia, M. Mourad, and G. , Phagocytosis of dialysis- 604 related amyloid deposits by macrophages, Nephrol Dial Transplant, vol.60517, pp.1136-1144, 2002.

T. Watanabe and T. Saniter, Morphological and clinical features of renal amyloidosis, Virchows Archiv A Pathological Anatomy and Histology, vol.21, issue.Suppl. 233, pp.125-160, 1975.
DOI : 10.1007/BF00433586

H. Shiiki, T. Shimokama, and Y. Yoshikawa, Renal amyloidosis. 609 Correlations between morphology, chemical types of amyloid protein 610 and clinical features, Virchows Arch A Pathol Anat Histopathol, vol.611412, pp.197-204, 1988.

L. Racusen, K. Solez, and R. Colvin, The Banff 97 working classification of renal allograft pathology, Kidney International, vol.55, issue.2, pp.713-736, 1999.
DOI : 10.1046/j.1523-1755.1999.00299.x

A. Sbai, B. Wechsler, and L. Leenhardt, Amyloid Goiter as the Initial Manifestation of Systemic Amyloidosis due to Familial Mediterranean Fever with Homozygous MEFV Mutation, Thyroid, vol.11, issue.4, pp.397-400, 2001.
DOI : 10.1089/10507250152039163

M. Gertz and R. Kyle, Secondary Systemic Amyloidosis, Medicine, vol.70, issue.4, pp.622-636, 1991.
DOI : 10.1097/00005792-199107000-00002

S. Janssen, M. Van-rijswijk, and S. Meijer, Systemic amyloidosis: a 625 clinical survey of 144 cases, Neth J Med, vol.29, pp.376-85, 1986.

P. Westermark, Aspects on human amyloid forms and their fibril polypeptides, FEBS Journal, vol.145, issue.23, pp.5942-5951, 2005.
DOI : 10.1111/j.1742-4658.2005.05024.x

G. Grateau, I. Jeru, and S. Rouaghe, Amyloidosis and Auto-Inflammatory Syndromes, Current Drug Target -Inflammation & Allergy, vol.4, issue.1, pp.57-65, 2005.
DOI : 10.2174/1568010053622786

S. Weiss and D. Page, Amyloid nephropathy of Ostertag with special 634

A. Sidoni, P. Alberti, and S. Bravi, Amyloid tumours in the soft tissues 640

K. Schafernak, S. Chugh, and Y. Kanwar, Co-existent crescentic 646 glomerulonephritis and renal amyloidosis: a case report and literature 647 review, J Nephrol, vol.18, pp.616-638, 2005.

C. Rocken, R. Menard, and F. Buhling, Proteolysis of serum amyloid A 653

A. Kebbel and C. Röcken, Immunohistochemical classification of amyloid 660

R. Hrncic, J. Wall, and D. Wolfenbarger, Antibody-mediated 662

G. Thomas and M. Davies, The potential role of human kidney cortex 674